SCHEMBL7658865

SCHEMBL7658865

O=C(NCc1cccc2ccccc12)[C@H]1CC[C@@H](Nc2nc3ccccc3[nH]2)CC1

nearest known ligand 0.56

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 3/20 0.54
NPC1 O15118 2/20 0.49
RAB9A P51151 2/20 0.49
TDP1 Q9NUW8 2/20 0.49
POLB P06746 1/20 0.49
ITGB3 P05106 2/20 0.46
ITGAV P06756 2/20 0.46
NQO2 P16083 1/20 0.45
LMNA P02545 1/20 0.44
MC4R P32245 2/20 0.44
MC1R Q01726 2/20 0.44
MC3R P41968 1/20 0.44
EPHX2 P34913 1/20 0.44
ALDH1A1 P00352 1/20 0.44
P2RX7 Q99572 1/20 0.44
MEN1 O00255 1/20 0.44
MAPT P10636 1/20 0.44
KMT2A Q03164 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7197538 1.00 SMN1; SMN2 (0.54) SMN1; SMN2NPC1RAB9ATDP1POLB
SCHEMBL7698279 0.88 ALDH1A1 (0.56) SMN1; SMN2NPC1RAB9ATDP1POLB
SCHEMBL7698276 0.88 ALDH1A1 (0.56) SMN1; SMN2NPC1RAB9ATDP1POLB
SCHEMBL7696476 0.87 SMN1; SMN2 (0.55) SMN1; SMN2NPC1RAB9ATDP1POLB
SCHEMBL7692146 0.87 LMNA (0.55) SMN1; SMN2NPC1RAB9ATDP1POLB
SCHEMBL7692144 0.87 LMNA (0.55) SMN1; SMN2NPC1RAB9ATDP1POLB
SCHEMBL7696480 0.87 SMN1; SMN2 (0.55) SMN1; SMN2NPC1RAB9ATDP1POLB
SCHEMBL7085647 0.86 SMN1; SMN2 (0.59) SMN1; SMN2NPC1RAB9ATDP1POLB
SCHEMBL7089468 0.86 SMN1; SMN2 (0.59) SMN1; SMN2NPC1RAB9ATDP1POLB
SCHEMBL7085654 0.86 SMN1; SMN2 (0.59) SMN1; SMN2NPC1RAB9ATDP1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6495561-B2 TREATING MIGRAINE, DEPRESSION, ANXIETY, SCHIZOPHRENIA, PARKINSON'S DISEASE, OR STROKE MERCK & CO., INC. 2002-12-17 US disclosed